Oral regimen ‘delays onset of MS’
Oral regimen ‘delays onset of MS’
For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome. In a phase III trial published in the journal Lancet Neurology, Miller et al clarified the role of teriflunomide (Aubagio) in the treatment of early episodes of demyelinating symptoms suggestive of MS...... Read More - http://www.ms-uk.org/aubagio
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 823 Views
-
Last post by NHE
-
- 0 Replies
- 2327 Views
-
Last post by frodo
-
- 0 Replies
- 1106 Views
-
Last post by NHE
-
- 0 Replies
- 1372 Views
-
Last post by frodo
-
- 1 Replies
- 1079 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1578 Views
-
Last post by NHE
-
- 0 Replies
- 2109 Views
-
Last post by vesta
-
- 1 Replies
- 1138 Views
-
Last post by Petr75